Product methodology
Capex and Facility Investment Tracker
Source contract, normalization path, entity-graph join, refresh posture, and publication limits for this Branmoor product.
Status
Pending. This product is pending. The methodology page is published first so the source contract and join path are visible before Branmoor represents the product as live.
Distribution Scope
Nationwide where source coverage exists; TN CON/permitting; Nashville hospital campus layer
Product Question
Evaluates whether a provider asset is investing, deferring, expanding, or carrying hidden facility risk.
Primary Sources
- CMS HCRIS and audited financials — Capital expense, depreciation, plant, and equipment context
- Certificate-of-need and state facility filings — Expansion and service-line investment signals
- Local building permits and parcel records — Campus construction, improvements, ownership, and assessed value
- FDA device and purchasing-adjacent records where available — Equipment and device-investment context
Entity-Graph Join
`ccn`, parcel ID, permit ID, CON docket, owner `irs_ein`, campus geocode, device/manufacturer IDs.
Publication Rule
Branmoor does not treat raw public records as the product. A surface is publishable only when the source record is dated, normalized, source-linked, and joined to the relevant Branmoor entity identifiers with enough confidence to state the limits of the result.
Current Methodology Note
Pending methodology. Local coverage is uneven; every geography carries coverage limits before capex claims are made.
Limits
Coverage follows the underlying source. Missing state portals, gated APIs, PDF-only filings, suppressed fields, lagged agency refreshes, and entity-name ambiguity can all limit product completeness. Pending products are not marketed as live until those limits are documented on the product surface.